UK Musculoskeletal Oncology: Something for All Ages. Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky
|
|
- Julius Price
- 5 years ago
- Views:
Transcription
1 UK Musculoskeletal Oncology: Something for All Ages Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky
2 Pediatric-Type Sarcomas of Bone and Soft Tissue The incidence of sarcoma continues to increase with age There is a distinctly different group of tumors that are seen almost exclusively in in children, adolescents, and young adults Tend to be high-grade tumors, often with chromosomal translocations Have frequent metastases, including to bone, nodes, and marrow Fortunately, they tend to be more chemoresponsive than adult sarcomas Bone: Osteosarcoma, Ewing sarcoma Soft tissue: Rhabdomyosarcoma, Synovial sarcoma
3 Sarcomas in Children and Adolescents Collectively make up 15% of all pediatric cancers, of which roughly half are soft tissue and half arise in the bone Rhabdomyosarcoma is the most common sarcoma in the first decade of life, and makes nearly 50% of all soft tissue sarcomas in pediatrics The other half are collectively called non-rhabdomyosarcoma soft tissue sarcoma Osteosarcoma and Ewing sarcoma peak in the second decade, and can be seen in young adults as well Importantly, the age distribution of these pediatric-type sarcomas does not arbitrarily cap off at 18 or 21 years
4 Relative Incidence of Soft Tissue Sarcoma By Age Albtritton, Hematol Oncol Clin N Am 2005
5 Histologic Subtype of Soft Tissue Sarcoma Varies By Age Albtritton, Hematol Oncol Clin N Am 2005
6 Sarcomas of Young Adults Roughly 3500 individuals per year between ages 15 and 29 are diagnosed with sarcoma Due to its aggressive nature, sarcoma disproportionately contributes to mortality compared to other cancers in this age group such as Hodgkin s disease and testicular cancer Because increasing age is a negative prognostic factor, these patients do worse than most patients cared for by pediatric oncologists, but still better than patients cared for by adult oncologists Care for these patients is complicated, and dispersed among a variety of medical settings
7 Prognosis for Young Adults with Sarcoma Prognosis worsens with age: 5-yr OS for localized RMS in young kids is > 75%, but in adults is <40% Synovial sarcoma risk of death increases 0.07 times for every year increase in age Survival worse with increasing age for both Ewing and osteosarcoma This worse prognosis likely reflect combination of: Biological differences in the tumors Tolerance of therapy Delays in diagnosis Physicians less familiar with the disease Lack of participation in, and availability of, clinical trials
8 Young Adults are Under-Represented in Clinical Trials for Soft Tissue Sarcoma Albtritton, Hematol Oncol Clin N Am 2005
9 Ongoing Sarcoma Research at UK Ongoing NCI-sponsored national Phase II clinical trial investigating a novel drug combination (cixutumumab + temsirolimus) for treatment of relapsed sarcoma (Wagner, PI) Proposed limited-institution trial investigating the addition of targeted agents to standard chemotherapy for newly-diagnosed osteosarcoma (Badgett, PI) Ongoing investigations to assess: Impact of early lymphocyte response after chemotherapy in osteosarcoma Role of sentinel node biopsy with SPECT/CT localization in pediatric sarcoma Methods to identify minimal residual disease in the bone marrow or blood in Ewing sarcoma patients Impact of thin-cut CT scans on number of lung nodules identified at surgery in pediatric sarcoma patients Role of bone scan vs. PET scan in osteosarcoma patients
10 Care for Adolescents and Young Adults with Sarcoma at UK It takes a village: Critical mass of specialists now assembled Orthopedic oncology Medical/pediatric oncology Radiation oncology Pathology Radiology (Diagnostic and Interventional) Social work Growing number of clinical trials and research opportunities Commitment to crossing artificial boundaries of age and care settings to provide high-quality, comprehensive care for these complex patients that suits their individual needs
Dr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationSarcomas. Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center
Sarcomas Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center Aaron Sugalski, DO Associate Professor of Pediatric Hematology/Oncology Medical Director, UHS Pediatric Blood and Cancer
More informationQuantitative Nuclear Medicine Imaging in Oncology. Susan E. Sharp, MD
Quantitative Nuclear Medicine Imaging in Oncology Susan E. Sharp, MD Disclosures None Objectives Describe scoring systems used in oncologic nuclear medicine imaging Deauville scoring in lymphoma Curie
More informationMusculoskeletal Sarcomas
Musculoskeletal Sarcomas Robert C. Orth, M.D., Ph.D. Edward B. Singleton Department of Pediatric Radiology Texas Children s Hospital Page 0 xxx00.#####.ppt 9/23/2012 9:01:18 AM No disclosures Page 1 xxx00.#####.ppt
More informationEffective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,
Ewing Tumor Perez Ewing tumor is the second most common primary tumor of bone in childhood, and also occurs in soft tissues Ewing tumor is uncommon before 8 years of age and after 25 years of age In the
More informationUpdate on Sarcomas of the Head and Neck. Kevin Harrington
Update on Sarcomas of the Head and Neck Kevin Harrington Overview Classification and incidence of sarcomas Clinical presentation Challenges to treatment Management approaches Prognostic factors Radiation-induced
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Solid Tumors of File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_solid_tumors_childhood
More informationSoft Tissue Sarcoma. Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee
Soft Tissue Sarcoma Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee Soft Tissue Sarcoma Collective term for an unusual and diverse
More informationSynovial Sarcoma. Dr. Michelle Ghert Dr. Rajiv Gandhi
Synovial Sarcoma Dr. Michelle Ghert Dr. Rajiv Gandhi Synovial Sarcoma Young adult population (15-40yrs) 5-10% of all soft tissue sarcomas mainly found in the extremities 5 year survival only 60% at presentation;
More informationLymphoma Read with the experts
Lymphoma Read with the experts Marc Seltzer, MD Associate Professor of Radiology Geisel School of Medicine at Dartmouth Director, PET-CT Course American College of Radiology Learning Objectives Recognize
More informationRare Cancers. Andrew J. Wagner, MD, PhD Center for Sarcoma and Bone Oncology Dana-Farber Cancer Institute Sarcoma Patient Symposium October 15, 2017
Rare Cancers Andrew J. Wagner, MD, PhD Center for Sarcoma and Bone Oncology Dana-Farber Cancer Institute Sarcoma Patient Symposium October 15, 2017 Why should we care about Rare Cancers? Raise your hand
More informationAll India Institute of Medical Sciences, New Delhi, INDIA. Department of Pediatric Surgery, Medical Oncology, and Radiology
All India Institute of Medical Sciences, New Delhi, INDIA Department of Pediatric Surgery, Medical Oncology, and Radiology Clear cell sarcoma of the kidney- rare renal neoplasm second most common renal
More informationLeslie Riley. Sarcoma Program AT SMILOW CANCER HOSPITAL
Leslie Riley Sarcoma Program AT SMILOW CANCER HOSPITAL The Sarcoma Program at Smilow Cancer Hospital is a multidisciplinary team of physicians specialized in the diagnosis, treatment, and care of patients
More informationState of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center
State of the Art Radiotherapy for Pediatric Tumors Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center Introduction Progress and success in pediatric oncology Examples of low-tech and high-tech
More informationFALCONS DISTRICT FOOTBALL CLUBS DRIVING SARCOMA AWARENESS & RAISING FUNDS FOR RESEARCH
FALCONS DISTRICT FOOTBALL CLUBS DRIVING SARCOMA AWARENESS & RAISING FUNDS FOR RESEARCH For more information contact: Falcons Football District/ WA Football Commission: Andrew Ridley Phone: 0402 794 016
More informationBone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors
Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors Lars Stegger, Benjamin Noto Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to
More informationCase Presentation. Gordon Callender M.D. Surgical Resident
Case Presentation Gordon Callender M.D. Surgical Resident Retroperitoneal Sarcomas Sarcomas Heterogeneous group of rare tumors that arise predominantly from the embryonic mesoderm. Expected incidence for
More informationThe Lymphomas. An overview..
The Lymphomas An overview.. Peter Anglin MD, FRCPC, MBA Stronach Regional Cancer Centre Newmarket, ON The lymphomas are an important part of the history of medicine 1666 Magpighi publishes first recorded
More informationNew Biological and Immunological Therapies for Cancer
New Biological and Immunological Therapies for Cancer Sant P. Chawla, M.D., FRACP The Sarcoma Oncology Center, Santa Monica CA 90403 7 th International Conference on Drug Discovery &Therapy 1 Promising
More informationExtraskeletal Osteosarcoma: Clinico-pathologic Features and Results of Multimodal Management
ecommons@aku Department of Radiology Medical College, Pakistan May 2010 Extraskeletal Osteosarcoma: Clinico-pathologic Features and Results of Multimodal Management Nicola Fabbri Akshay Tiwari masood umer
More information28 OI November December A Medical Home for Adolescents and Young Adults with Cancer
28 OI November December 2013 www.accc-cancer.org A Medical Home for Adolescents and Young Adults with Cancer By Douglas S. Hawkins, MD Our team consists of more than 30 doctors specializing in cancers
More informationClinical indications for positron emission tomography
Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will
More information2008 Oncology Pharmacy Preparatory Review Course Learning Objectives
2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,
More informationGuide to Understanding Lung Cancer
Guide to Understanding Lung Cancer Lung cancer is the second most common cancer overall for men and women in the U.S., with an estimated 222,500 new cases in 2017. However, lung cancer is the most common
More informationPET/CT Frequently Asked Questions
PET/CT Frequently Asked Questions General Q: Is FDG PET specific for cancer? A: No, it is a marker of metabolism. In general, any disease that causes increased metabolism can result in increased FDG uptake
More informationSubspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident
Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Residents: Pediatric residents at the PL3 level Prerequisites: Successful completion or waiver
More information2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives
2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives Acute Leukemia/Tumor Lysis Syndrome John M. Valgus, Pharm.D., BCOP Hematology/Oncology Specialist University of North
More informationPediatric Oncology. Vlad Radulescu, MD
Pediatric Oncology Vlad Radulescu, MD Objectives Review the epidemiology of childhood cancer Discuss the presenting signs and symptoms, general treatment principles and overall prognosis of the most common
More informationIntroduction to Musculoskeletal Tumors. James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon
Introduction to Musculoskeletal Tumors James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon www.tumorsurgery.org Definitions Primary Bone / Soft tissue tumors Mesenchymally derived tumors (Mesodermal)
More informationSmall Cell Lung Cancer
Small Cell Lung Cancer Small cell lung cancer (SCLC) affects 15% of all lung cancer patients. SCLC is the most aggressive type of lung cancer. It may be treated with chemotherapy and radiation. SCLC has
More informationDr.Dafalla Ahmed Babiker Jazan University
Dr.Dafalla Ahmed Babiker Jazan University Brain tumors are the second commonest malignancy in children Infratentorial tumors are more common As a general rule they do not metastasize out of the CNS, but
More informationNuclear medicine in oncology. 1. Diagnosis 2. Therapy
Nuclear medicine in oncology 1. Diagnosis 2. Therapy Diagnosis - Conventional methods - Nonspecific radiopharmaceuticals cumulating in tumours - Specific radiopharmaceuticals (receptor- and immunoscintigraphy)
More informationWHAT ARE PAEDIATRIC CANCERS
WHAT ARE PAEDIATRIC CANCERS INTRODUCTION Childhood cancers are RARE 0.5% of all cancers in the West Overall risk that a child will develop cancer during first 15 years of life is 1 in 450 and 1 in 600
More informationSurgical Management of Pulmonary Metastases. Dr AG Jacobs Principal Specialist Dept Cardiothoracic Surgery Steve Biko Academic Hospital
Surgical Management of Pulmonary Metastases Dr AG Jacobs Principal Specialist Dept Cardiothoracic Surgery Steve Biko Academic Hospital Introduction Lungs 2 nd most common site of metastatic deposition
More informationWhat is Cancer? Understanding the basics of
What is Cancer? Understanding the basics of A process of physical and biological changes that occur when normal healthy cells are transformed into cancer cells What is Cancer? Cancer is an umbrella term
More informationFAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated
Page 1 of 5 COG-AEWS1221: Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly
More informationInstructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113)
Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the CLL Post-HSCT Data Form. E-mail
More informationCase 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset
Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or
More informationRadiation and Hodgkin s Disease: A Changing Field. Sravana Chennupati Radiation Oncology PGY-2
Radiation and Hodgkin s Disease: A Changing Field Sravana Chennupati Radiation Oncology PGY-2 History of Present Illness 19 yo previously healthy male college student began having pain in his R shoulder
More information2007 ANNUAL SITE STUDY HODGKIN S LYMPHOMA
2007 ANNUAL SITE STUDY HODGKIN S LYMPHOMA SUSQUEHANNA HEALTH David B. Nagel, M.D. April 11, 2008 Hodgkin s lymphoma was first described by Thomas Hodgkin in 1832. It remained an incurable malignancy until
More informationANZUP SURVEILLANCE RECOMMENDATIONS FOR METASTATIC TESTICULAR CANCER POST-CHEMOTHERAPY
ANZUP SURVEILLANCE RECOMMENDATIONS FOR METASTATIC TESTICULAR CANCER POST-CHEMOTHERAPY Note: These surveillance recommendations are provided as recommendations only. Clinicians should take into account
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Ablative therapy, nonsurgical, for pulmonary metastases of soft tissue sarcoma, 279 280 Adipocytic tumors, atypical lipomatous tumor vs. well-differentiated
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationCurriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center
MEDICAL ONCOLOGY AND HEMATOLOGY (R2, R3) A. The PURPOSE of this rotation is to afford medical residents a broad clinical and training experience in the clinical diagnosis and management of common adult
More informationThe orthopedic-oncology service : a multidisciplinary team
The orthopedic-oncology service : a multidisciplinary team The orthopedic-oncology service at Maisonneuve- Rosemont Hospital provides care to patients from the many regions of Quebec and the Maritimes.
More informationRole, timing and technique of radiotherapy in pediatric pleuropulmonary synovial sarcoma
SUPPLEMENT For reprint orders, please contact: reprints@futuremedicine.com Role, timing and technique of radiotherapy in pediatric pleuropulmonary synovial sarcoma Corrado Spatola*,1, Alessandra Tocco
More informationKlinisch belang van chromosomale translocatie detectie in sarcomen
Translocations in sarcomas Klinisch belang van chromosomale translocatie detectie in sarcomen Judith V.M.G. Bovée, M.D., Ph.D. Department of Pathology Leiden University Medical Center RNA binding DNA binding
More information* I have no disclosures or any
Howard Rosenthal, M.D. Associate Professor of Orthopedic Surgery University of Kansas Sarcoma Center I have no disclosures or any conflicts related to the content of this presentation. Objectives 1. Describe
More informationPathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON
Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Presentation outline Background and epidemiology of sarcomas Sarcoma classification Sarcoma
More informationCancer in adolescents and Young Adults
17 th ESO-ESMO Masterclass in Clinical Oncology 24-29 March 2018, Cancer in adolescents and Young Adults Laurence Brugières Gustave Roussy Cancer Center Villejuif, France Cancer in TYA A rare disease in
More informationA CASE OF PRIMARY THYROID LYMPHOMA. Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey
A CASE OF PRIMARY THYROID LYMPHOMA Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey 38 year old female She recognized a mass in her right neck
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationPediatric Lymphoma Update from the Children s Oncology Group
Pediatric Lymphoma Update from the Children s Oncology Group Stephan D. Voss, MD, PhD Department of Radiology Boston Children s Hospital Harvard Medical School Staging Assessment Disclosures None Acknowledgements:
More informationIntroduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT
Introduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT protocols Tips Leukaemia / lymphoma: ~ 35% acute lymphoblastic
More informationVernon K. Sondak. Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida
Vernon K. Sondak Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida Australasian Melanoma Conference 2016 Sydney, NSW, Australia October 29, 2016 Disclosures Dr. Sondak is a compensated
More informationPET-imaging: when can it be used to direct lymphoma treatment?
PET-imaging: when can it be used to direct lymphoma treatment? Luca Ceriani Nuclear Medicine and PET-CT centre Oncology Institute of Southern Switzerland Bellinzona Disclosure slide I declare no conflict
More informationPET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET
Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to
More informationPRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019
MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments
More informationLocal Therapy for Ewing Sarcoma: Current Concepts and Opportunities for Improvement
Local Therapy for Ewing Sarcoma: Current Concepts and Opportunities for Improvement Safia K. Ahmed, MD Department of Radiation Oncology Washington University August 25, 2017 2017 MFMER slide-1 Outline
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationA Guide to Ewing Sarcoma
A Guide to Ewing Sarcoma Written By Physicians For Physicians WHAT IS EWING SARCOMA (ES) ES is a malignant bone tumor that can evolve from any bone in the body (and occasionally soft tissue) and mostly
More informationMelanoma Quality Reporting
Melanoma Quality Reporting September 1, 2013 December 31, 2016 Laurence McCahill, MD Surgical Oncologist Metro Health Surgical Oncology Metro Health Professional Building 2122 Health Drive SW Wyoming,
More informationSIOP Europe the European Society for Paediatric Oncology European Network for Cancer Research in Children and Adolescents
the European Society for Paediatric Oncology encca European Network for Cancer Research in Children and Adolescents EUROPEAN TRAINING PROGRAMME IN PAEDIATRIC HAEMATOLOGY AND ONCOLOGY EUROPEAN BOARD OF
More informationLYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center
LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center Lymphoma is cancer of the lymphatic system. The lymphatic system is made up of organs all over the body that make up and store cells
More informationLymph Node Management in Patients With Paratesticular Rhabdomyosarcoma
Original Article Lymph Node Management in Patients With Paratesticular Rhabdomyosarcoma A Population-Based Analysis Nguyen D. Dang, MD 1 ; Phuong-Thanh Dang, BS 2 ; Jason Samuelian, DO 1 ; and Arnold C.
More informationPEDIATRIC. BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a COMPANION STUDIES
PEDIATRIC BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in other than Average Risk Medulloblastoma/PNET Patients. https://clinicaltrials.gov/ct2/show/nct00392327?term=0332&rank=6
More informationLugano classification: Role of PET-CT in lymphoma follow-up
CAR Educational Exhibit: ID 084 Lugano classification: Role of PET-CT in lymphoma follow-up Charles Nhan 4 Kevin Lian MD Charlotte J. Yong-Hing MD FRCPC Pete Tonseth 3 MD FRCPC Department of Diagnostic
More informationGuidelines for Specialist Referral in Newly Identified Bone Lesions
Evidence Based Medicine Committee: Patrick J. Getty, MD Eric R. Henderson MD (Lead Author) Lawrence R. Menendez, MD Benjamin J. Miller, MD (Chair) Christian M. Ogilvie, MD Rajiv Rajani, MD Felasfa Wodajo,
More informationCURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of )
Leukemia AALL0932 closed after Induction CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 10.10.2017) Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized
More informationAdjuvant therapy for thyroid cancer
Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women
More informationBone HDR brachytherapy in a patient with recurrent Ewing s sarcoma of the acetabulum: Alternative to aggressive surgery
Bone HDR brachytherapy in a patient with recurrent Ewing s sarcoma of the acetabulum: Alternative to aggressive surgery Rafael Martínez-Monge 1,* Agata Pérez-Ochoa 1, Mikel San Julián 2, Dámaso Aquerreta
More informationMonophasic Synovial Carcinoma of knee joint- A Case Report and Review of Literature
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 3 Ver.5 March. (2018), PP 13-17 www.iosrjournals.org Monophasic Synovial Carcinoma of knee
More informationASPS Recommended Insurance Coverage Criteria for Third- Party Payers
ASPS Recommended Insurance Coverage Criteria for Third- Party Payers Breast Implant Associated Anaplastic Large Cell Lymphoma BACKGROUND Anaplastic Large Cell Lymphoma (ALCL) is a rare type of cancer of
More informationA Phase I Dose Escalation Study of Intratumoral Herpes Simplex Virus 1 Mutant rrp450 in Patients with Refractory Sarcoma or Neuroblastoma
A Phase I Dose Escalation Study of Intratumoral Herpes Simplex Virus 1 Mutant rrp450 in Patients with Refractory Sarcoma or Neuroblastoma Timothy P. Cripe, M.D., Ph.D. Associate Professor Division of Hematology/Oncology
More informationPrimary bone tumors > metastases from other sites Primary bone tumors widely range -from benign to malignant. Classified according to the normal cell
Primary bone tumors > metastases from other sites Primary bone tumors widely range -from benign to malignant. Classified according to the normal cell counterpart and line of differentiation. Among the
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
PET Scanning: Oncologic Applications Page 1 of 88 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Positron Emission Tomography (PET) Scanning: Oncologic Applications
More informationDiagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017
Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD November 18, 2017 Disclosures I do not have a financial interest/arrangement or affiliation with one or more organizations
More informationGuidelines for Specialist Referral for Newly Identified Bone Lesions
MSTS Evidence Based Medicine Committee: Eric R. Henderson MD (Lead Author) Patrick J. Getty, MD Lawrence R. Menendez, MD Benjamin J. Miller, MD Christian M. Ogilvie, MD Rajiv Rajani, MD Steven W. Thorpe,
More informationSoft Tissue Sarcomas: Questions and Answers
Soft Tissue Sarcomas: Questions and Answers 1. What is soft tissue? The term soft tissue refers to tissues that connect, support, or surround other structures and organs of the body. Soft tissue includes
More informationNon-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)
Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma
More informationChapter 10. Summary, conclusions and future perspectives
Chapter 10 Summary, conclusions and future perspectives 10.1 SUMMARY In this thesis, a new tumor imaging tracer in nuclear medicine is studied. This 123 tracer, L-3-[ I]Iodo-alpha-methyl-tyrosine (IMT),
More informationStaging: Recommendations for bone marrow investigations
International Workshop for PET in Lymphoma Staging and Restaging Thursday October 4th, Menton. Staging: Recommendations for bone marrow investigations Martin Hutchings Department of Haematology Rigshospitalet,
More informationSolomon Graf, MD February 22, 2013
Solomon Graf, MD February 22, 2013 Case Review of FL pathology, prognosis Grading of FL Grade 3 disease High proliferative index in grade 1/2 disease Pediatric FL Future of FL classification 57 yo man
More informationLos Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010
Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted
More informationNON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)
NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Michelle Geddes (Staff Hematologist, University of Calgary) and Dr.
More informationSoluble CD155 As A Biomarker For Malignant Bone And Soft Tissue Tumors
Soluble CD155 As A Biomarker For Malignant Bone And Soft Tissue Tumors Mikinobu Goto, MD, Akihiko Matsumine, MD,PhD, Tomoki Nakamura, MD PhD, Takao Matsubara, MD PhD, Kunihiro Asanuma, MD,PhD, Toru Oi,
More informationJAMES EWING, Endothelial origin. 14 yr Girl
JAMES EWING, 1921 Endothelial origin 14 yr Girl SPECTRUM OF ESFT NEURAL DIFFERENTIATION Least Well EWING S SARCOMA ATYPICAL EWING S SARCOMA PNET Peripheral Neuroepithelioma ASKIN TUMOR (thoraco-pulmonary)
More informationPelvic tumor in childhood Classification, imaging approach and radiological findings
Pelvic tumor in childhood Classification, imaging approach and radiological findings M. Mearadji International Foundation for Pediatric Imaging Aid Rotterdam, The Netherlands Solid pelvic masses in childhood
More information-Proton Beam Therapy in Paediatric Radiation Oncology -
-Proton Beam Therapy in Paediatric Radiation Oncology - Beate Timmermann, M.D. West German Proton Therapy Centre Essen Germany Preview Survival Toxicity Why protons? (theoretically) Experiences so far
More informationSOLID TUMOURS IN CHILDHOOD
SOLID TUMOURS IN CHILDHOOD Fareed Omar Paediatric Oncology Steve Biko Academic hospital Introduction 1 Introduction Lymphomas and Leukemias make up about 40% of all childhood Cancers (Systemic cancers)
More informationSoft Tissue Sarcoma Early Detection, Diagnosis, and Staging
Soft Tissue Sarcoma Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can
More informationWhat is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine
What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Layman s terms: cancer starts when cells grow out of control (in any place in the body) and crowd out normal cells
More informationManaging adult soft tissue sarcomas and gastrointestinal stromal tumours
Managing adult soft tissue sarcomas and gastrointestinal stromal tumours Sarcomas and gastrointestinal stromal tumours include a wide variety of biologically diverse cancers, many of them very rare. Paolo
More informationFDG-PET/CT in the management of lymphomas
FDG-PET/CT in the management of lymphomas Olivier Gheysens, MD, PhD Dept. of Nuclear Medicine, UZ Leuven BHS, Feb 4th 2017 Brussels Dept. of Nuclear Overview Introduction on FDG-PET/CT Staging Response
More informationNY-ESO SPEAR T-cells in Synovial Sarcoma
NY-ESO SPEAR T-cells in Synovial Sarcoma ASCO Update June 6, 2017 Disclaimer This presentation contains forward-looking statements, as that term is defined under the Private Securities Litigation Reform
More informationIntrarenal Extension. sinus
Intrarenal Extension into sinus Document Capsular Penetration sinus 16 Pediatric Renal Tumor Staging Stage I Limited to Kidney & Completely Resected Intact Renal Capsule No Previous Rupture or Biopsy Renal
More informationSubject: PET Scan With or Without CT Attenuation. Original Effective Date: 11/7/2017. Policy Number: MCR: 610. Revision Date(s): Review Date:
Subject: PET Scan With or Without CT Attenuation Policy Number: MCR: 610 Revision Date(s): MHW Original Effective Date: 11/7/2017 Review Date: DISCLAIMER This Molina Clinical Review (MCR) is intended to
More informationEpidemiological impact of HIV on Non-Hodgkin s lymphoma in Zimbabwe ( )
Research article Epidemiological impact of HIV on Non-Hodgkin s lymphoma in Zimbabwe (2004-2007) Webster Kadzatsa 1, Ntokozo Ndlovu 1, Nomsa Tsikai 1 1 Radiotherapy and Oncology, College of Health Science,
More informationPediatric cancer. Kleebsabai Sanpakit, MD. Hemato/Oncology division, Department of Pediatrics Faculty of Medicine Siriraj hospital
Pediatric cancer เทคน คการให รห สโรค Siriraj Cancer ICD-O Registry ฉบ บม ออาช พ Kleebsabai Sanpakit, MD. Hemato/Oncology division, Department of Pediatrics Faculty of Medicine Siriraj hospital Different
More informationPDF created with pdffactory Pro trial version
Neuroblastoma Tumor derived from neural crest cell that form the sympathetic ganglia&adrenal medulla. Causes *unknown. *familial neuroblastoma has been reported but is rare. * The incidence is 1:100,000
More information